Sep 12, 2023 8:15am EDT FibroBiologics Dedicates Laboratory Facility as the Newlin-Linscomb Lab for Cell Therapeutics
Jun 01, 2023 4:37pm EDT FibroBiologics to Present Corporate Update at 2023 BIO International Convention
Feb 24, 2023 9:07am EST FibroBiologics Sets Another Record as Highest Amount Raised per Biotech Investor in StartEngine.com History
Feb 01, 2023 3:41pm EST FibroBiologics Sets Record as Fastest Rising Biotech in History with StartEngine.com
May 31, 2022 9:13am EDT FibroBiologics Presents Preclinical Data at the 2022 Consortium of Multiple Sclerosis Centers Annual Meeting
Mar 10, 2022 9:38am EST FibroBiologics Adds Microbiologist Kathleen "Kate" Rubins, Ph.D. to Scientific Advisory Board
Nov 16, 2021 10:07am EST FibroBiologics Secures $100 Million Capital Commitment from GEM as Company Seeks to Go Public